Oncotarget is a multidisciplinary medical journal, with free-access. The journal was officially rolled out back in 2010. It publishes papers on oncology, the study of cancers and tumors, every week. Users can obtain a printed version of the paper of their interest upon placing a special request. The platform’s mission is to make scientific results rapidly and widely available. By so doing, it allows exceptional discoveries to be shared quickly. Oncotarget ranks the top position among the journals that covers oncological research.
Cancers and tumors
All of the body cells have a tightly regulated system that controls their growth, maturity, reproduction, and eventually death. Cancer begins when some of the body cells experience abnormal growth. It affects millions of people worldwide. In the U.S. close to a third of all women and half of all men, develop cancer during their lifetime. Tumors, on the other hand, refer to a mass or growth of tissue. It can be benign, which is harmless, or malignant, which is cancerous. Learn more about Oncotarget at Research Gate.
Importance of Oncotarget Journal
Without a doubt, cancer and tumors pose a global threat. Having a hub where new ideas and findings on Oncology can be published is paramount. For instance, Professor Irfan Rahman of the revered UR School of Medicine and Dentistry has been a regular contributor in the field of oncology. He and his team at the University Of Rochester Medical Center made a scientific breakthrough after discovering that electronic cigarettes are as equally damaging to gums and teeth as conventional cigarettes. The findings were provided to the thousands of users on Oncotarget. Similar findings are easily posted on Oncotarget for promoting research and equipping readers with knowledge.
What makes Oncotarget an incredible medical journal?
1.) Cost friendly: Oncotarget has free access to its authors and users.
2.) Convenient: There are thousands of web-based blogs. Having an international hub where all new findings can be placed, makes it easy for readers working in the same field to access updates.
3.) Credibility: Authors are free to talk with the press starting from the day their research paper are accepted. All articles posted are relevant to Oncology.